Key result
Elevated CRP/albumin ratio linked to angiographic no-reflow during NSTEMI PCI.
Why the study?
This study evaluated the predictive value of the high-sensitivity C-reactive protein/albumin ratio for angiographic no-reflow in NSTEMI patients undergoing PCI.
Does the high-sensitivity C-reactive protein/albumin ratio (CAR) predict angiographic no-reflow in NSTEMI patients undergoing PCI?
Observational (n=400)
Does the high-sensitivity C-reactive protein/albumin ratio (CAR) predict angiographic no-reflow in NSTEMI patients undergoing PCI?
Elevated high-sensitivity C-reactive protein/albumin ratio is associated with angiographic no-reflow in NSTEMI patients undergoing PCI.
Answers are grounded in this paper and cite their sources.
May identify higher no-reflow risk in NSTEMI PCI; hypothesis-generating and requires prospective validation before clinical use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Çelik et al. (2026) conducted an observational in NSTEMI (n=400). High-sensitivity C-reactive protein/albumin ratio (CAR) was evaluated on Angiographic no-reflow (TIMI ≤2). Elevated high-sensitivity C-reactive protein/albumin ratio (CAR) was associated with angiographic no-reflow in NSTEMI patients undergoing PCI (median CAR 0.27 vs. 0.13).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: